Demonstration of Biosimilarity, Extrapolation of Indications and Other Challenges Related to Biosimilars in Europe

Drift, Evolution, and Divergence in Biologics and Biosimilars Manufacturing

(2014) Sundar Ramanan et al.   BIODRUGS

Development and Regulation of Biosimilars: Current Status and Future Challenges

(2013) Asterios S. Tsiftsoglou et al.   BIODRUGS

Biosimilars: what clinicians should know

(2012) M. Weise et al.   BLOOD

The State of the Art in the Development of Biosimilars

(2012) Mark McCamish et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Setting the stage for biosimilar monoclonal antibodies

(2012) Christian K Schneider et al.   NATURE BIOTECHNOLOGY

In support of the European Union biosimilar framework

(2012) Christian K Schneider et al.   NATURE BIOTECHNOLOGY

Potential Intussusception Risk Versus Benefits of Rotavirus Vaccination in the United States

(2012) Rishi Desai et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Economic issues with follow-on protein products

(2008) Michael Lanthier et al.   NATURE REVIEWS DRUG DISCOVERY

Protein therapeutics: a summary and pharmacological classification

(2007) Benjamin Leader et al.   NATURE REVIEWS DRUG DISCOVERY